ROIV · Roivant Sciences Ltd.
Trades by corporate insiders — officers, directors and holders of more than 10% of the shares — disclosed to the SEC on Forms 3, 4 and 5. Form 4 must be filed within two business days of the trade.
Insider Sentiment Score
Peer-relative 0–100 rank of how aggressively insiders accumulated over the trailing 90 days. See the full ranking.
| Date | Insider | Role | Type | Security | Shares |
|---|---|---|---|---|---|
| 2026-07-27 | Venker Eric |
President & Immunovant CEO |
Convert↑
|
Common Shares
|
200,000 |
| 2026-07-27 | Venker Eric |
President & Immunovant CEO |
Sell↓
Filing footnotes — Common Shares (Direct)
The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $34.62 to $35.56, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Common Shares sold at each separate price within the range. |
Common Shares
|
200,000 |
| 2026-07-27 | Venker Eric |
President & Immunovant CEO |
Convert↓
Filing footnotes — Stock Option (Right to Buy) (Direct)
Reflects an award of stock options to purchase Common Shares that is fully vested. |
Stock Option (Right to Buy)
|
200,000 |
| 2026-07-17 | MOMTAZEE JAMES C |
Director |
Award↑
Filing footnotes — Common Shares (Direct)
Reflects an award of Common Shares received pursuant to the Issuer's Non-Employee Director Compensation Plan that was fully vested as of the grant date. |
Common Shares
|
405 |
| 2026-07-17 | Oren Ilan |
Director |
Award↑
Filing footnotes — Common Shares (Direct)
Reflects an award of Common Shares received pursuant to the Issuer's Non-Employee Director Compensation Plan that was fully vested as of the grant date. |
Common Shares
|
775 |
| 2026-07-17 | Epperly Melissa B, |
Director |
Award↑
Filing footnotes — Common Shares (Direct)
Reflects an award of Common Shares received pursuant to the Issuer's Non-Employee Director Compensation Plan that was fully vested as of the grant date. |
Common Shares
|
543 |
| 2026-06-30 | MANCHESTER KEITH S |
Director |
Sell↓
Filing footnotes — Common Shares (Indirect)
The reporting person is a shareholder of QVT Financial Investment Cayman Ltd. ("QVT FIC") but does not have any voting or investment control over QVT FIC. The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these Common Shares in this report shall not be deemed an admission of beneficial ownership of all of the reported Common Shares for purposes of Section 16 or for any other purpose. |
Common Shares
(I)
|
12,380 |
| 2026-06-30 | Gline Matthew |
Director, CEO |
Tax↓
Filing footnotes — Common Shares (Direct)
Represents the "net settlement" by the Issuer of RSUs previously granted to the reporting person in order to satisfy applicable tax withholding obligations in connection with the vesting and settlement of such RSUs. |
Common Shares
|
76,171 |
| 2026-06-30 | Gold Daniel Allen |
Director |
Sell↓
Filing footnotes — Common Shares (Indirect)
The reporting person is one of three directors of QVT Financial Investment Cayman Ltd. ("QVT FIC"), sharing voting and investment control over the Common Shares held directly by QVT FIC. The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these Common Shares in this report shall not be deemed an admission of beneficial ownership of all of the reported Common Shares for purposes of Section 16 or for any other purpose. |
Common Shares
(I)
|
12,380 |
| 2026-06-30 | QVT Financial LP |
Insider |
Sell↓
Filing footnotes — Common Shares (Indirect)
Aggregately, following the transactions described above, QVT Financial LP ("QVT"), a Delaware limited partnership, may be deemed to be the beneficial owner of 23,723,074 Common Shares, consisting of the Common Shares owned by QVT P&E Roiv Hldgs Ltd. ("QVT P&E"), QVT Deferred Compensation Holdings Ltd ("QVT DCH") and QVT FIC. QVT Financial GP LLC ("QVT Financial GP"), a Delaware limited liability company, is the general partner of QVT and may be deemed to beneficially own the same number of Common Shares reported by QVT. QVT provides certain investment advisory services for, and thereby may be deemed to beneficially own the Common Shares held by, QVT P&E, QVT DCH and QVT FIC. QVT disclaims beneficial ownership of such Common Shares, except to the extent of any pecuniary interest therein, and the inclusion of these Common Shares in this report shall not be deemed an admission of beneficial ownership of all of the reported Common Shares for purposes of Section 16 or for any other purpose. |
Common Shares
(I)
|
12,380 |
| 2026-06-30 | Torti Frank |
President and Vant Chair |
Tax↓
Filing footnotes — Common Shares (Direct)
Represents the "net settlement" by the Issuer of RSUs previously granted to the reporting person in order to satisfy applicable tax withholding obligations in connection with the vesting and settlement of such RSUs. |
Common Shares
|
40,310 |
| 2026-06-30 | Fitzgerald Meghan |
Director |
Convert↓
Filing footnotes — Stock Option (Right to Buy) (Direct)
Award of stock options to purchase Common Shares that is fully vested. |
Stock Option (Right to Buy)
|
10,000 |
| 2026-06-30 | Sukhatme Mayukh |
Director, President & CIO |
Tax↓
Filing footnotes — Common Shares (Direct)
Represents the "net settlement" by the Issuer of RSUs previously granted to the reporting person in order to satisfy applicable tax withholding obligations in connection with the vesting and settlement of such RSUs. |
Common Shares
|
46,878 |
| 2026-06-30 | Fitzgerald Meghan |
Director |
Sell↓
|
Common Shares
|
10,000 |
| 2026-06-30 | Fitzgerald Meghan |
Director |
Convert↑
|
Common Shares
|
10,000 |
| 2026-06-30 | MANCHESTER KEITH S |
Director |
Sell↓
|
Common Shares
|
200,000 |
| 2026-06-29 | Epperly Melissa B, |
Director |
Convert↑
|
Common Shares
|
17,750 |
| 2026-06-29 | QVT Financial LP |
Insider |
Sell↓
Filing footnotes — Common Shares (Indirect)
Aggregately, following the transactions described above, QVT Financial LP ("QVT"), a Delaware limited partnership, may be deemed to be the beneficial owner of 23,723,074 Common Shares, consisting of the Common Shares owned by QVT P&E Roiv Hldgs Ltd. ("QVT P&E"), QVT Deferred Compensation Holdings Ltd ("QVT DCH") and QVT FIC. QVT Financial GP LLC ("QVT Financial GP"), a Delaware limited liability company, is the general partner of QVT and may be deemed to beneficially own the same number of Common Shares reported by QVT. QVT provides certain investment advisory services for, and thereby may be deemed to beneficially own the Common Shares held by, QVT P&E, QVT DCH and QVT FIC. QVT disclaims beneficial ownership of such Common Shares, except to the extent of any pecuniary interest therein, and the inclusion of these Common Shares in this report shall not be deemed an admission of beneficial ownership of all of the reported Common Shares for purposes of Section 16 or for any other purpose. |
Common Shares
(I)
|
600,000 |
| 2026-06-29 | MANCHESTER KEITH S |
Director |
Sell↓
Filing footnotes — Common Shares (Indirect)
The reporting person is a shareholder of QVT Financial Investment Cayman Ltd. ("QVT FIC") but does not have any voting or investment control over QVT FIC. The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these Common Shares in this report shall not be deemed an admission of beneficial ownership of all of the reported Common Shares for purposes of Section 16 or for any other purpose. |
Common Shares
(I)
|
600,000 |
| 2026-06-29 | Epperly Melissa B, |
Director |
Convert↓
Filing footnotes — Stock Option (Right to Buy) (Direct)
Reflects an award of stock options to purchase Common Shares that is fully vested. |
Stock Option (Right to Buy)
|
17,750 |
| 2026-06-29 | Gold Daniel Allen |
Director |
Sell↓
Filing footnotes — Common Shares (Indirect)
The reporting person is one of three directors of QVT Financial Investment Cayman Ltd. ("QVT FIC"), sharing voting and investment control over the Common Shares held directly by QVT FIC. The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these Common Shares in this report shall not be deemed an admission of beneficial ownership of all of the reported Common Shares for purposes of Section 16 or for any other purpose. |
Common Shares
(I)
|
600,000 |
| 2026-06-29 | Epperly Melissa B, |
Director |
Sell↓
Filing footnotes — Common Shares (Direct)
The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $34.65 to $34.80, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Common Shares sold at each separate price within the range. |
Common Shares
|
2,748 |
| 2026-06-29 | QVT Financial LP |
Insider |
Sell↓
Filing footnotes — Common Shares (Indirect)
Aggregately, following the transactions described above, QVT Financial LP ("QVT"), a Delaware limited partnership, may be deemed to be the beneficial owner of 23,723,074 Common Shares, consisting of the Common Shares owned by QVT P&E Roiv Hldgs Ltd. ("QVT P&E"), QVT Deferred Compensation Holdings Ltd ("QVT DCH") and QVT FIC. QVT Financial GP LLC ("QVT Financial GP"), a Delaware limited liability company, is the general partner of QVT and may be deemed to beneficially own the same number of Common Shares reported by QVT. QVT provides certain investment advisory services for, and thereby may be deemed to beneficially own the Common Shares held by, QVT P&E, QVT DCH and QVT FIC. QVT disclaims beneficial ownership of such Common Shares, except to the extent of any pecuniary interest therein, and the inclusion of these Common Shares in this report shall not be deemed an admission of beneficial ownership of all of the reported Common Shares for purposes of Section 16 or for any other purpose. |
Common Shares
(I)
|
200,000 |
| 2026-06-29 | Epperly Melissa B, |
Director |
Sell↓
Filing footnotes — Common Shares (Direct)
The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $33.65 to $34.64, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Common Shares sold at each separate price within the range. |
Common Shares
|
15,002 |
| 2026-06-29 | Gold Daniel Allen |
Director |
Sell↓
Filing footnotes — Common Shares (Indirect)
The reporting person is one of three directors of QVT Financial Investment Cayman Ltd. ("QVT FIC"), sharing voting and investment control over the Common Shares held directly by QVT FIC. The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these Common Shares in this report shall not be deemed an admission of beneficial ownership of all of the reported Common Shares for purposes of Section 16 or for any other purpose. |
Common Shares
(I)
|
200,000 |
| 2026-06-29 | MANCHESTER KEITH S |
Director |
Sell↓
Filing footnotes — Common Shares (Indirect)
The reporting person is a shareholder of QVT Financial Investment Cayman Ltd. ("QVT FIC") but does not have any voting or investment control over QVT FIC. The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these Common Shares in this report shall not be deemed an admission of beneficial ownership of all of the reported Common Shares for purposes of Section 16 or for any other purpose. |
Common Shares
(I)
|
200,000 |
| 2026-06-26 | Gold Daniel Allen |
Director |
Sell↓
Filing footnotes — Common Shares (Indirect)
The reporting person is one of three directors of QVT Financial Investment Cayman Ltd. ("QVT FIC"), sharing voting and investment control over the Common Shares held directly by QVT FIC. The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these Common Shares in this report shall not be deemed an admission of beneficial ownership of all of the reported Common Shares for purposes of Section 16 or for any other purpose. |
Common Shares
(I)
|
325,000 |
| 2026-06-26 | MANCHESTER KEITH S |
Director |
Sell↓
Filing footnotes — Common Shares (Indirect)
The reporting person is a shareholder of QVT Financial Investment Cayman Ltd. ("QVT FIC") but does not have any voting or investment control over QVT FIC. The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these Common Shares in this report shall not be deemed an admission of beneficial ownership of all of the reported Common Shares for purposes of Section 16 or for any other purpose. |
Common Shares
(I)
|
300,783 |
| 2026-06-26 | QVT Financial LP |
Insider |
Sell↓
Filing footnotes — Common Shares (Indirect)
Aggregately, following the transactions described above, QVT Financial LP ("QVT"), a Delaware limited partnership, may be deemed to be the beneficial owner of 23,723,074 Common Shares, consisting of the Common Shares owned by QVT P&E Roiv Hldgs Ltd. ("QVT P&E"), QVT Deferred Compensation Holdings Ltd ("QVT DCH") and QVT FIC. QVT Financial GP LLC ("QVT Financial GP"), a Delaware limited liability company, is the general partner of QVT and may be deemed to beneficially own the same number of Common Shares reported by QVT. QVT provides certain investment advisory services for, and thereby may be deemed to beneficially own the Common Shares held by, QVT P&E, QVT DCH and QVT FIC. QVT disclaims beneficial ownership of such Common Shares, except to the extent of any pecuniary interest therein, and the inclusion of these Common Shares in this report shall not be deemed an admission of beneficial ownership of all of the reported Common Shares for purposes of Section 16 or for any other purpose. |
Common Shares
(I)
|
325,000 |
| 2026-06-26 | Gold Daniel Allen |
Director |
Sell↓
Filing footnotes — Common Shares (Indirect)
The reporting person is one of three directors of QVT Financial Investment Cayman Ltd. ("QVT FIC"), sharing voting and investment control over the Common Shares held directly by QVT FIC. The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these Common Shares in this report shall not be deemed an admission of beneficial ownership of all of the reported Common Shares for purposes of Section 16 or for any other purpose. |
Common Shares
(I)
|
300,783 |
| 2026-06-26 | Sukhatme Mayukh |
Director, President & CIO |
Sell↓
Filing footnotes — Common Shares (Direct)
The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $33.75 to $34.45, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Common Shares sold at each separate price within the range. |
Common Shares
|
500,000 |
| 2026-06-26 | QVT Financial LP |
Insider |
Sell↓
Filing footnotes — Common Shares (Indirect)
Aggregately, following the transactions described above, QVT Financial LP ("QVT"), a Delaware limited partnership, may be deemed to be the beneficial owner of 23,723,074 Common Shares, consisting of the Common Shares owned by QVT P&E Roiv Hldgs Ltd. ("QVT P&E"), QVT Deferred Compensation Holdings Ltd ("QVT DCH") and QVT FIC. QVT Financial GP LLC ("QVT Financial GP"), a Delaware limited liability company, is the general partner of QVT and may be deemed to beneficially own the same number of Common Shares reported by QVT. QVT provides certain investment advisory services for, and thereby may be deemed to beneficially own the Common Shares held by, QVT P&E, QVT DCH and QVT FIC. QVT disclaims beneficial ownership of such Common Shares, except to the extent of any pecuniary interest therein, and the inclusion of these Common Shares in this report shall not be deemed an admission of beneficial ownership of all of the reported Common Shares for purposes of Section 16 or for any other purpose. |
Common Shares
(I)
|
300,783 |
| 2026-06-26 | Sukhatme Mayukh |
Director, President & CIO |
Convert↑
|
Common Shares
|
500,000 |
| 2026-06-26 | Sukhatme Mayukh |
Director, President & CIO |
Convert↓
Filing footnotes — Stock Option (Right to Buy) (Direct)
Award of stock options to purchase Common Shares that is fully vested. |
Stock Option (Right to Buy)
|
500,000 |
| 2026-06-26 | MANCHESTER KEITH S |
Director |
Sell↓
Filing footnotes — Common Shares (Indirect)
The reporting person is a shareholder of QVT Financial Investment Cayman Ltd. ("QVT FIC") but does not have any voting or investment control over QVT FIC. The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these Common Shares in this report shall not be deemed an admission of beneficial ownership of all of the reported Common Shares for purposes of Section 16 or for any other purpose. |
Common Shares
(I)
|
325,000 |
| 2026-06-25 | Sukhatme Mayukh |
Director, President & CIO |
Convert↓
Filing footnotes — Stock Option (Right to Buy) (Direct)
Award of stock options to purchase Common Shares that is fully vested. |
Stock Option (Right to Buy)
|
500,000 |
| 2026-06-25 | Sukhatme Mayukh |
Director, President & CIO |
Convert↑
|
Common Shares
|
500,000 |
| 2026-06-25 | Sukhatme Mayukh |
Director, President & CIO |
Sell↓
Filing footnotes — Common Shares (Direct)
The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $33.87 to $34.67, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Common Shares sold at each separate price within the range. |
Common Shares
|
500,000 |
| 2026-06-24 | Venker Eric |
President & Immunovant CEO |
Convert↑
|
Common Shares
|
200,000 |
| 2026-06-24 | Venker Eric |
President & Immunovant CEO |
Convert↓
Filing footnotes — Stock Option (Right to Buy) (Direct)
Reflects an award of stock options to purchase Common Shares that is fully vested. |
Stock Option (Right to Buy)
|
200,000 |
| 2026-06-24 | Venker Eric |
President & Immunovant CEO |
Sell↓
Filing footnotes — Common Shares (Direct)
The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $32.23 to $33.22, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Common Shares sold at each separate price within the range. |
Common Shares
|
153,766 |
| 2026-06-24 | Venker Eric |
President & Immunovant CEO |
Sell↓
Filing footnotes — Common Shares (Direct)
The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $33.23 to $33.98, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Common Shares sold at each separate price within the range. |
Common Shares
|
46,234 |
| 2026-06-20 | Humes Jennifer |
Chief Accounting Officer |
Tax↓
Filing footnotes — Common Shares (Direct)
Represents the "net settlement" by the Issuer of RSUs previously granted to the reporting person in order to satisfy applicable tax withholding obligations in connection with the vesting and settlement of such RSUs. |
Common Shares
|
3,582 |
| 2026-06-20 | Pulik Richard |
CFO |
Tax↓
Filing footnotes — Common Shares (Direct)
Represents the "net settlement" by the Issuer of RSUs previously granted to the reporting person in order to satisfy applicable tax withholding obligations in connection with the vesting and settlement of such RSUs. |
Common Shares
|
2,129 |
| 2026-05-22 | Venker Eric |
President & Immunovant CEO |
Sell↓
Filing footnotes — Common Shares (Direct)
The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.00 to $30.55, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Common Shares sold at each separate price within the range. |
Common Shares
|
200,000 |
| 2026-05-22 | Venker Eric |
President & Immunovant CEO |
Convert↑
|
Common Shares
|
200,000 |
| 2026-05-22 | Venker Eric |
President & Immunovant CEO |
Convert↓
Filing footnotes — Stock Option (Right to Buy) (Direct)
Reflects an award of stock options to purchase Common Shares that is fully vested. |
Stock Option (Right to Buy)
|
200,000 |
| 2026-05-20 | Venker Eric |
President & Immunovant CEO |
Tax↓
Filing footnotes — Common Shares (Direct)
Represents the "net settlement" by the Issuer of RSUs previously granted to the reporting person in order to satisfy applicable tax withholding obligations in connection with the vesting and settlement of such RSUs. |
Common Shares
|
34,483 |
| 2026-05-20 | Pulik Richard |
CFO |
Tax↓
Filing footnotes — Common Shares (Direct)
Represents the "net settlement" by the Issuer of RSUs previously granted to the reporting person in order to satisfy applicable tax withholding obligations in connection with the vesting and settlement of such RSUs. |
Common Shares
|
18,962 |
| 2026-04-20 | Pulik Richard |
CFO |
Award↑
Filing footnotes — Common Shares (Direct)
Reflects an award of restricted stock units with respect to Common Shares ("RSUs") with a vesting commencement date of April 20, 2026. These RSUs vest (i) 25% on the first anniversary of the vesting commencement date and (ii) in twelve (12) successive equal quarterly installments thereafter, measured from the first anniversary of the vesting commencement date, subject to the reporting person's continuous service through the applicable vesting date. |
Common Shares
|
60,644 |